SlideShare una empresa de Scribd logo
1 de 41
Neurocommunication

   Brian J. Piper, Ph.D.
Terminology
• Neurotransmitter: chemical that is released in
  the brain and has an effect on a local target
• Hormone: chemical that is released into
  bloodstream that has an effect on a distant
  target
Goals
• Neurotransmission
  – History
  – Onset: Neurotransmitter release (classical and
    non-classical)
  – Offset: autoreceptors, transporters, enzymes
  – Receptor Families
• Endocrine
History: Golgi vs. Cajal
• Italian physician
• Reticulum theory
• Silver stain




                          Camillo Golgi (1843-1926)
Controversy: Golgi vs. Cajal
                          • Santiogo Ramon y Cajal
                               – Neuroanatomist
                               – Used Golgi’s technique
                               – Neuron theory




1852-1934



                Chicken cerebellum
Neural Communication
 The body’s information system is built from
billions of interconnected cells called neurons.
   Communication between neurons is both
             electrical and chemical.
Otto Loewi
• Discovered “Vagusstoff” later
  known as acetylcholine
• “father of neuroscience”
• Nobel Prize 1936
What are amino acids?
• Amine (NH2) + Carboxyl ( -COOH)
• 20 total, 9 essential




                    tyrosine        Tryptophan
More terminology
• Peptides: short (<50) strings of amino acids,
  Valine-Glycine-Serine-Alanine… e.g. NPY




                                    C terminal: COOH
                                    N terminal: NH2
                                    Arginine, Proline, Lysine, Phenylalanine,
                                    Methionine, Histidine, Aspartic Acid, Valine
More terminology
• Peptides: short (<50) strings of amino acids,
  Valine-Glycine-Serine-Alanine… e.g. NPY
More terminology
Proteins: longer strings of amino acids, have 3-D
structure, form receptors, transporters
Comparison
                     Peptide             Protein
Size (amino acids)   < 40                >40
Dimensions           1-D                 3-D
Complexity           Low                 High




                            Hemoglobin
“Typical” Synapse
Electron Microscope
• Beams of electrons are presented to a thin
  section, 50 pm (10-12) resolution
• Reveals different types of Synapses
Dendritic Spine
Axodendritic Synapse
Axosomatic Synapse
Neurotransmitter Criteria
•    1) Found and made presynaptically.
•    2) Mechanism for inactivation.
•    3) Stimulating neuron releases it.
•    4) Receptors found postsynaptically.
•    5) Applying substance has biological effect.
•    6) Antagonizing inhibits biological effect.



    “neuromodulators”
Neurotransmitter Comparison
                Classical   Non-Classical
Discovery       1950’s      1980’s
Concentration   High        Low
#               Few         Many
Synthesis       Anywhere    Soma
Classical Neurotransmitters
• Monoamines: dopamine, norepinephrine,
  serotonin
• Acetylcholine (ACh)
• Amino Acids: glycine, GABA, Glutamate
Non-classical Neurotransmitters
• Peptides: Corticotropin-releasing factor (CRF),
  endorphins
• Lipids: Anandamide
• Gases: Nitric Oxide
Co-Transmitters
  Amine/Amino Acid                             Peptide
  Dopamine                                     Cholecystokinin (CCK)
  Norepinephrine                               enkephalin
  Epinephrine                                  neurotensin
  Serotonin                                    substance P
  Acetylcholine                                somatostatin
  Gamma aminobutyric acid (GABA)               motilin




Stahl, S. (2000). Essential Psychopharmacology, p. 20.
Axon Terminal
Brakes II
• Autoreceptors: this receptor (“auto” = “self”)
  can act to inhibit further neurotransmitter
  release
  – Terminal (axon) autoreceptors: inhibit
    neurotransmitter release
  – Somatodendritic autoreceptors: reduce rate of
    action potentials
Brakes I
• Enzyme: A + B __ENZ____> AB
• Enzyme: CD    __ENZ____> C + D
Transporters
• Proteins that move molecule from one place
  to another, examples:
  – SERT: serotonin transporter
  – NET: norepinephrine transporter
  – DAT: dopamine transporter



                            Inside
                            ----------------------------------------------------------------------
                            Outside
Post-synaptic
• Ligand: substance that binds to a receptor
• Ion: atom where # electrons ≠ # protons
  – Ca2+ Na+     K+
  – Cl-
• First messenger: neurotransmitter
• Second messenger: other molecule
• Kinase: enzyme that adds phosphate (PO4)
Types of Receptors
So Many Receptors!
           Serotonin (5-HT):
           1
           2
           3
           4
           5
           6
           7
Family 1: Ionotropic
• Binding to receptor opens channel to let ions
  in (aka: ligand gated ion receptors)
Family 1: Ionotropic
  • Binding to receptor opens channel to let ions
    in (aka: ligand gated ion receptors)




0:40 – 6:20: http://www.youtube.com/watch?v=8jPH2pKzIDY
Family 2: Metabotropic (2nd messenger)
• Steps:
• 1) Ligand binds receptor
• 2) G protein acts on enzyme
• 3) Enzyme regulates 2nd
  messenger
• 4) 2nd messenger acts on
      protein kinase

    6:30-9:00 http://www.youtube.com/watch?v=8jPH2pKzIDY
Family 2: Metabotropic (Channel)
• Steps:
• 1) Ligand binds receptor
• 2) G protein alters
  channel
• 3) ions flow out of
   neuron
Receptor Families Compared
                 Ionotropic                 Metabotropic
Subunits         4-5                        1
Mechanism        Simple: Channel opening    Complex: G protein cascade
2nd messengers   No                         Yes
Speed            Fast                       Slow




                                           Meyer & Quenzer (2005). p 73
Family 3: Tyrosine Kinase
• Steps:
1) Ligand (BDNF) binds to Trk receptor
2) Trk receptors come together, and
phosphorylate each other
So many drug targets!!!
                  Examples:
                  1) Tryptophan
                  6) Nicotine
                  10) MAO-I
                  11) SSRIs
Endocrine System
Gland      Hormone (Function)
Pineal     Melatonin (light-dark rhythm)
Thyroid    T3/T4 (energy)
Adrenal    Cortisol (stress)
Pancreas   Insulin (glucose)
Ovaries    Estrogens (2nd sex characteristics)
Testes     Androgens (2nd sex characteristics)
Example
    • Rats that received ecstasy (MDMA) during
      adolescence were more sensitive to a 5-HT2
      agonist when adults




Biezonski et al. (2009). Brain Research, 1252, 87-93.
Reference

Más contenido relacionado

La actualidad más candente

screening of anxiolytics
screening of anxiolyticsscreening of anxiolytics
screening of anxiolytics
Sayanti Sau
 
Anxiolytic screening models_utkarsh
Anxiolytic screening models_utkarshAnxiolytic screening models_utkarsh
Anxiolytic screening models_utkarsh
Utkarsh Alok
 

La actualidad más candente (20)

Preclinical Screening for Neurodegenerative Disease (Parkinsonism)
Preclinical Screening for Neurodegenerative Disease (Parkinsonism)Preclinical Screening for Neurodegenerative Disease (Parkinsonism)
Preclinical Screening for Neurodegenerative Disease (Parkinsonism)
 
CNS pharmacology
CNS pharmacologyCNS pharmacology
CNS pharmacology
 
Screening of anti alzheimers
Screening of anti alzheimersScreening of anti alzheimers
Screening of anti alzheimers
 
screening of anxiolytics
screening of anxiolyticsscreening of anxiolytics
screening of anxiolytics
 
Screening of antidepressant agents
Screening of antidepressant agentsScreening of antidepressant agents
Screening of antidepressant agents
 
Alzheimer's disease pharmacotherapy
Alzheimer's disease pharmacotherapyAlzheimer's disease pharmacotherapy
Alzheimer's disease pharmacotherapy
 
serotonin/neurotransmitter
serotonin/neurotransmitterserotonin/neurotransmitter
serotonin/neurotransmitter
 
Pharmacological screening of Anti-psychotic agents
Pharmacological screening of Anti-psychotic agentsPharmacological screening of Anti-psychotic agents
Pharmacological screening of Anti-psychotic agents
 
Cns stimulants and depressants screening models
Cns stimulants and depressants screening modelsCns stimulants and depressants screening models
Cns stimulants and depressants screening models
 
Anxiolytic screening models_utkarsh
Anxiolytic screening models_utkarshAnxiolytic screening models_utkarsh
Anxiolytic screening models_utkarsh
 
Neurotransmitters
NeurotransmittersNeurotransmitters
Neurotransmitters
 
Screening Methods of Parkinson's Disease
Screening Methods of Parkinson's DiseaseScreening Methods of Parkinson's Disease
Screening Methods of Parkinson's Disease
 
Screening of Anxiolytics
Screening of AnxiolyticsScreening of Anxiolytics
Screening of Anxiolytics
 
Screening method of nootropics vikas malik
Screening method of nootropics vikas malikScreening method of nootropics vikas malik
Screening method of nootropics vikas malik
 
Serotonergic system ravi
Serotonergic system raviSerotonergic system ravi
Serotonergic system ravi
 
Muscle relaxants by ved prakash
Muscle relaxants by ved prakashMuscle relaxants by ved prakash
Muscle relaxants by ved prakash
 
Parasympathomimetic drugs
Parasympathomimetic drugs Parasympathomimetic drugs
Parasympathomimetic drugs
 
Neurohumoral transmission in ans
Neurohumoral transmission  in  ansNeurohumoral transmission  in  ans
Neurohumoral transmission in ans
 
Anesthesia and euthanasia of experimental animal by vivek and naveen
Anesthesia and euthanasia of experimental animal by vivek and naveenAnesthesia and euthanasia of experimental animal by vivek and naveen
Anesthesia and euthanasia of experimental animal by vivek and naveen
 
Behavior and muscle coordination
Behavior and muscle coordinationBehavior and muscle coordination
Behavior and muscle coordination
 

Destacado

INTRODUCTION TO AUTONOMIC PHARMACOLOGY Part III - Mechanism
INTRODUCTION TO AUTONOMIC PHARMACOLOGY Part III - Mechanism INTRODUCTION TO AUTONOMIC PHARMACOLOGY Part III - Mechanism
INTRODUCTION TO AUTONOMIC PHARMACOLOGY Part III - Mechanism
pharmdude
 
Schizofrenia e patologia mentale grave
Schizofrenia e patologia mentale graveSchizofrenia e patologia mentale grave
Schizofrenia e patologia mentale grave
Raffaele Barone
 
Schizofrenia e patologia mentale grave
Schizofrenia e patologia mentale graveSchizofrenia e patologia mentale grave
Schizofrenia e patologia mentale grave
Raffaele Barone
 

Destacado (20)

Neuropharmacology: Schizophrenia
Neuropharmacology: SchizophreniaNeuropharmacology: Schizophrenia
Neuropharmacology: Schizophrenia
 
INTRODUCTION TO AUTONOMIC PHARMACOLOGY Part III - Mechanism
INTRODUCTION TO AUTONOMIC PHARMACOLOGY Part III - Mechanism INTRODUCTION TO AUTONOMIC PHARMACOLOGY Part III - Mechanism
INTRODUCTION TO AUTONOMIC PHARMACOLOGY Part III - Mechanism
 
Tokoh psikologi
Tokoh psikologiTokoh psikologi
Tokoh psikologi
 
Schizofrenia e patologia mentale grave
Schizofrenia e patologia mentale graveSchizofrenia e patologia mentale grave
Schizofrenia e patologia mentale grave
 
Schizofrenia e patologia mentale grave
Schizofrenia e patologia mentale graveSchizofrenia e patologia mentale grave
Schizofrenia e patologia mentale grave
 
Neuropharmacology: Inhalants
Neuropharmacology: InhalantsNeuropharmacology: Inhalants
Neuropharmacology: Inhalants
 
Examination of Sexually Dimorphic Behavior on the Novel-Image Novel-Location ...
Examination of Sexually Dimorphic Behavior on the Novel-Image Novel-Location ...Examination of Sexually Dimorphic Behavior on the Novel-Image Novel-Location ...
Examination of Sexually Dimorphic Behavior on the Novel-Image Novel-Location ...
 
Il Cervello Umano
Il Cervello UmanoIl Cervello Umano
Il Cervello Umano
 
Schizophrenia
SchizophreniaSchizophrenia
Schizophrenia
 
Pharmacotherapies for neurodegenerative disorders
Pharmacotherapies for neurodegenerative disordersPharmacotherapies for neurodegenerative disorders
Pharmacotherapies for neurodegenerative disorders
 
Migraine and 5-HT
Migraine and 5-HTMigraine and 5-HT
Migraine and 5-HT
 
Pathophysiology: Neuroanatomy Part I
Pathophysiology: Neuroanatomy Part IPathophysiology: Neuroanatomy Part I
Pathophysiology: Neuroanatomy Part I
 
Pharmacotherapies for parkinsons disease
Pharmacotherapies for parkinsons diseasePharmacotherapies for parkinsons disease
Pharmacotherapies for parkinsons disease
 
ADHD Drugs
ADHD DrugsADHD Drugs
ADHD Drugs
 
Psychopharmacology of Anxiety Disorders I: GAD & SAD
Psychopharmacology of Anxiety Disorders I: GAD & SADPsychopharmacology of Anxiety Disorders I: GAD & SAD
Psychopharmacology of Anxiety Disorders I: GAD & SAD
 
Neurotransmission
NeurotransmissionNeurotransmission
Neurotransmission
 
Drug Abuse & Society (RX 462) Presentations-Spring 2014
Drug Abuse & Society (RX 462) Presentations-Spring 2014Drug Abuse & Society (RX 462) Presentations-Spring 2014
Drug Abuse & Society (RX 462) Presentations-Spring 2014
 
electronic cigarettes
electronic cigaretteselectronic cigarettes
electronic cigarettes
 
Neuropharmacology: Hallucinogens
Neuropharmacology: HallucinogensNeuropharmacology: Hallucinogens
Neuropharmacology: Hallucinogens
 
Neuromuscular junction & autonomic ganglia
Neuromuscular junction & autonomic gangliaNeuromuscular junction & autonomic ganglia
Neuromuscular junction & autonomic ganglia
 

Similar a Neuropharmacology: Neurotransmission

An Introduction to Neurotransmitter System
An Introduction to Neurotransmitter SystemAn Introduction to Neurotransmitter System
An Introduction to Neurotransmitter System
Madan Baral
 
Neurochemistry
NeurochemistryNeurochemistry
Neurochemistry
Mahin Nwx
 
Neurotransmiters of ans synthesis and fate
Neurotransmiters of ans  synthesis and fateNeurotransmiters of ans  synthesis and fate
Neurotransmiters of ans synthesis and fate
Zulcaif Ahmad
 
Neurotransmission ubc
Neurotransmission ubcNeurotransmission ubc
Neurotransmission ubc
YazeedMD
 
Y1S2 Synapse NMJ Neurotransmitters
Y1S2 Synapse NMJ NeurotransmittersY1S2 Synapse NMJ Neurotransmitters
Y1S2 Synapse NMJ Neurotransmitters
vajira54
 
97308319-Neurotransmitter-and-Its-Synapses-Ppt.pdf
97308319-Neurotransmitter-and-Its-Synapses-Ppt.pdf97308319-Neurotransmitter-and-Its-Synapses-Ppt.pdf
97308319-Neurotransmitter-and-Its-Synapses-Ppt.pdf
boscokiuria
 

Similar a Neuropharmacology: Neurotransmission (20)

Cell signaling
Cell signalingCell signaling
Cell signaling
 
NTs_2.ppt
NTs_2.pptNTs_2.ppt
NTs_2.ppt
 
Nerurons.ppt
Nerurons.pptNerurons.ppt
Nerurons.ppt
 
Role of Neurotransmitters with their detailed description
Role of Neurotransmitters with their detailed descriptionRole of Neurotransmitters with their detailed description
Role of Neurotransmitters with their detailed description
 
An Introduction to Neurotransmitter System
An Introduction to Neurotransmitter SystemAn Introduction to Neurotransmitter System
An Introduction to Neurotransmitter System
 
Neurochemistry
NeurochemistryNeurochemistry
Neurochemistry
 
Neurotransmiters of ans synthesis and fate
Neurotransmiters of ans  synthesis and fateNeurotransmiters of ans  synthesis and fate
Neurotransmiters of ans synthesis and fate
 
Neurotransmission ubc
Neurotransmission ubcNeurotransmission ubc
Neurotransmission ubc
 
Ch 11c
Ch 11cCh 11c
Ch 11c
 
Ch 11c
Ch 11cCh 11c
Ch 11c
 
CNS.ppt
CNS.pptCNS.ppt
CNS.ppt
 
BCM-Neurochemistry.pdf
BCM-Neurochemistry.pdfBCM-Neurochemistry.pdf
BCM-Neurochemistry.pdf
 
Y1S2 Synapse NMJ Neurotransmitters
Y1S2 Synapse NMJ NeurotransmittersY1S2 Synapse NMJ Neurotransmitters
Y1S2 Synapse NMJ Neurotransmitters
 
97308319-Neurotransmitter-and-Its-Synapses-Ppt.pdf
97308319-Neurotransmitter-and-Its-Synapses-Ppt.pdf97308319-Neurotransmitter-and-Its-Synapses-Ppt.pdf
97308319-Neurotransmitter-and-Its-Synapses-Ppt.pdf
 
Signal transmission at synapse
Signal transmission at synapseSignal transmission at synapse
Signal transmission at synapse
 
Overview of the Nervous System.pptx
Overview of the Nervous System.pptxOverview of the Nervous System.pptx
Overview of the Nervous System.pptx
 
Cell physiology1.
Cell physiology1.Cell physiology1.
Cell physiology1.
 
snaptic transmission.pptx
snaptic transmission.pptxsnaptic transmission.pptx
snaptic transmission.pptx
 
Nerve transmission
Nerve transmissionNerve transmission
Nerve transmission
 
Nerve transmission
Nerve transmissionNerve transmission
Nerve transmission
 

Más de Brian Piper

Más de Brian Piper (20)

Current recreational drugs: RX462 Drug Abuse & Society, Spring 2015 Class pre...
Current recreational drugs: RX462 Drug Abuse & Society, Spring 2015 Class pre...Current recreational drugs: RX462 Drug Abuse & Society, Spring 2015 Class pre...
Current recreational drugs: RX462 Drug Abuse & Society, Spring 2015 Class pre...
 
Drug abuse and society drug presentations: Spring 2013
Drug abuse and society drug presentations: Spring 2013Drug abuse and society drug presentations: Spring 2013
Drug abuse and society drug presentations: Spring 2013
 
Sedative & Hypnotic Drugs Part II
Sedative & Hypnotic Drugs Part IISedative & Hypnotic Drugs Part II
Sedative & Hypnotic Drugs Part II
 
Sedative & Hypnotic Agents Part I
Sedative & Hypnotic Agents Part ISedative & Hypnotic Agents Part I
Sedative & Hypnotic Agents Part I
 
Agents for Bipolar
Agents for BipolarAgents for Bipolar
Agents for Bipolar
 
Psychopharmacology of Anxiety: Part II OCD & PTSD
Psychopharmacology of Anxiety: Part II OCD & PTSDPsychopharmacology of Anxiety: Part II OCD & PTSD
Psychopharmacology of Anxiety: Part II OCD & PTSD
 
Antipsychotics Part II
Antipsychotics Part IIAntipsychotics Part II
Antipsychotics Part II
 
Antipsychotics I
Antipsychotics IAntipsychotics I
Antipsychotics I
 
Anti Inflammation agents for CNS
Anti Inflammation agents for CNSAnti Inflammation agents for CNS
Anti Inflammation agents for CNS
 
Antidepressants Part II
Antidepressants Part IIAntidepressants Part II
Antidepressants Part II
 
Antidepressants Part I
Antidepressants Part IAntidepressants Part I
Antidepressants Part I
 
Anticonvulsants Part II
Anticonvulsants Part IIAnticonvulsants Part II
Anticonvulsants Part II
 
Anticonvulsants Part I
Anticonvulsants Part IAnticonvulsants Part I
Anticonvulsants Part I
 
Agents for Brain Injury
Agents for Brain InjuryAgents for Brain Injury
Agents for Brain Injury
 
Pathophysiology: Myasthenia Gravis & Restless Leg Syndrome
Pathophysiology: Myasthenia Gravis & Restless Leg SyndromePathophysiology: Myasthenia Gravis & Restless Leg Syndrome
Pathophysiology: Myasthenia Gravis & Restless Leg Syndrome
 
Pathophysiology: Migraine & Headache
Pathophysiology: Migraine & HeadachePathophysiology: Migraine & Headache
Pathophysiology: Migraine & Headache
 
Pathophysiology: Alzheimer's Disease
Pathophysiology: Alzheimer's DiseasePathophysiology: Alzheimer's Disease
Pathophysiology: Alzheimer's Disease
 
Pathophysiology: Introduction to Neuropsychiatry
Pathophysiology: Introduction to Neuropsychiatry Pathophysiology: Introduction to Neuropsychiatry
Pathophysiology: Introduction to Neuropsychiatry
 
Pathophysiology: Neuroanatomy Part II
Pathophysiology: Neuroanatomy Part IIPathophysiology: Neuroanatomy Part II
Pathophysiology: Neuroanatomy Part II
 
Antiemetics
AntiemeticsAntiemetics
Antiemetics
 

Último

Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Safe Software
 
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
?#DUbAI#??##{{(☎️+971_581248768%)**%*]'#abortion pills for sale in dubai@
 

Último (20)

Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...
Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...
Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...
 
FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024
 
Data Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt RobisonData Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt Robison
 
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
 
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
 
Apidays Singapore 2024 - Scalable LLM APIs for AI and Generative AI Applicati...
Apidays Singapore 2024 - Scalable LLM APIs for AI and Generative AI Applicati...Apidays Singapore 2024 - Scalable LLM APIs for AI and Generative AI Applicati...
Apidays Singapore 2024 - Scalable LLM APIs for AI and Generative AI Applicati...
 
Axa Assurance Maroc - Insurer Innovation Award 2024
Axa Assurance Maroc - Insurer Innovation Award 2024Axa Assurance Maroc - Insurer Innovation Award 2024
Axa Assurance Maroc - Insurer Innovation Award 2024
 
Manulife - Insurer Transformation Award 2024
Manulife - Insurer Transformation Award 2024Manulife - Insurer Transformation Award 2024
Manulife - Insurer Transformation Award 2024
 
Artificial Intelligence Chap.5 : Uncertainty
Artificial Intelligence Chap.5 : UncertaintyArtificial Intelligence Chap.5 : Uncertainty
Artificial Intelligence Chap.5 : Uncertainty
 
Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...
 
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
 
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
 
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWEREMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
 
MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024
 
Automating Google Workspace (GWS) & more with Apps Script
Automating Google Workspace (GWS) & more with Apps ScriptAutomating Google Workspace (GWS) & more with Apps Script
Automating Google Workspace (GWS) & more with Apps Script
 
A Year of the Servo Reboot: Where Are We Now?
A Year of the Servo Reboot: Where Are We Now?A Year of the Servo Reboot: Where Are We Now?
A Year of the Servo Reboot: Where Are We Now?
 
Real Time Object Detection Using Open CV
Real Time Object Detection Using Open CVReal Time Object Detection Using Open CV
Real Time Object Detection Using Open CV
 
Navi Mumbai Call Girls 🥰 8617370543 Service Offer VIP Hot Model
Navi Mumbai Call Girls 🥰 8617370543 Service Offer VIP Hot ModelNavi Mumbai Call Girls 🥰 8617370543 Service Offer VIP Hot Model
Navi Mumbai Call Girls 🥰 8617370543 Service Offer VIP Hot Model
 
Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...
Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...
Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...
 
Corporate and higher education May webinar.pptx
Corporate and higher education May webinar.pptxCorporate and higher education May webinar.pptx
Corporate and higher education May webinar.pptx
 

Neuropharmacology: Neurotransmission

  • 1. Neurocommunication Brian J. Piper, Ph.D.
  • 2. Terminology • Neurotransmitter: chemical that is released in the brain and has an effect on a local target • Hormone: chemical that is released into bloodstream that has an effect on a distant target
  • 3. Goals • Neurotransmission – History – Onset: Neurotransmitter release (classical and non-classical) – Offset: autoreceptors, transporters, enzymes – Receptor Families • Endocrine
  • 4. History: Golgi vs. Cajal • Italian physician • Reticulum theory • Silver stain Camillo Golgi (1843-1926)
  • 5. Controversy: Golgi vs. Cajal • Santiogo Ramon y Cajal – Neuroanatomist – Used Golgi’s technique – Neuron theory 1852-1934 Chicken cerebellum
  • 6. Neural Communication The body’s information system is built from billions of interconnected cells called neurons. Communication between neurons is both electrical and chemical.
  • 7. Otto Loewi • Discovered “Vagusstoff” later known as acetylcholine • “father of neuroscience” • Nobel Prize 1936
  • 8. What are amino acids? • Amine (NH2) + Carboxyl ( -COOH) • 20 total, 9 essential tyrosine Tryptophan
  • 9. More terminology • Peptides: short (<50) strings of amino acids, Valine-Glycine-Serine-Alanine… e.g. NPY C terminal: COOH N terminal: NH2 Arginine, Proline, Lysine, Phenylalanine, Methionine, Histidine, Aspartic Acid, Valine
  • 10. More terminology • Peptides: short (<50) strings of amino acids, Valine-Glycine-Serine-Alanine… e.g. NPY
  • 11. More terminology Proteins: longer strings of amino acids, have 3-D structure, form receptors, transporters
  • 12. Comparison Peptide Protein Size (amino acids) < 40 >40 Dimensions 1-D 3-D Complexity Low High Hemoglobin
  • 14. Electron Microscope • Beams of electrons are presented to a thin section, 50 pm (10-12) resolution • Reveals different types of Synapses
  • 18. Neurotransmitter Criteria • 1) Found and made presynaptically. • 2) Mechanism for inactivation. • 3) Stimulating neuron releases it. • 4) Receptors found postsynaptically. • 5) Applying substance has biological effect. • 6) Antagonizing inhibits biological effect. “neuromodulators”
  • 19. Neurotransmitter Comparison Classical Non-Classical Discovery 1950’s 1980’s Concentration High Low # Few Many Synthesis Anywhere Soma
  • 20. Classical Neurotransmitters • Monoamines: dopamine, norepinephrine, serotonin • Acetylcholine (ACh) • Amino Acids: glycine, GABA, Glutamate
  • 21. Non-classical Neurotransmitters • Peptides: Corticotropin-releasing factor (CRF), endorphins • Lipids: Anandamide • Gases: Nitric Oxide
  • 22. Co-Transmitters Amine/Amino Acid Peptide Dopamine Cholecystokinin (CCK) Norepinephrine enkephalin Epinephrine neurotensin Serotonin substance P Acetylcholine somatostatin Gamma aminobutyric acid (GABA) motilin Stahl, S. (2000). Essential Psychopharmacology, p. 20.
  • 24. Brakes II • Autoreceptors: this receptor (“auto” = “self”) can act to inhibit further neurotransmitter release – Terminal (axon) autoreceptors: inhibit neurotransmitter release – Somatodendritic autoreceptors: reduce rate of action potentials
  • 25. Brakes I • Enzyme: A + B __ENZ____> AB • Enzyme: CD __ENZ____> C + D
  • 26. Transporters • Proteins that move molecule from one place to another, examples: – SERT: serotonin transporter – NET: norepinephrine transporter – DAT: dopamine transporter Inside ---------------------------------------------------------------------- Outside
  • 27.
  • 28. Post-synaptic • Ligand: substance that binds to a receptor • Ion: atom where # electrons ≠ # protons – Ca2+ Na+ K+ – Cl- • First messenger: neurotransmitter • Second messenger: other molecule • Kinase: enzyme that adds phosphate (PO4)
  • 30. So Many Receptors! Serotonin (5-HT): 1 2 3 4 5 6 7
  • 31. Family 1: Ionotropic • Binding to receptor opens channel to let ions in (aka: ligand gated ion receptors)
  • 32. Family 1: Ionotropic • Binding to receptor opens channel to let ions in (aka: ligand gated ion receptors) 0:40 – 6:20: http://www.youtube.com/watch?v=8jPH2pKzIDY
  • 33. Family 2: Metabotropic (2nd messenger) • Steps: • 1) Ligand binds receptor • 2) G protein acts on enzyme • 3) Enzyme regulates 2nd messenger • 4) 2nd messenger acts on protein kinase 6:30-9:00 http://www.youtube.com/watch?v=8jPH2pKzIDY
  • 34. Family 2: Metabotropic (Channel) • Steps: • 1) Ligand binds receptor • 2) G protein alters channel • 3) ions flow out of neuron
  • 35. Receptor Families Compared Ionotropic Metabotropic Subunits 4-5 1 Mechanism Simple: Channel opening Complex: G protein cascade 2nd messengers No Yes Speed Fast Slow Meyer & Quenzer (2005). p 73
  • 36. Family 3: Tyrosine Kinase • Steps: 1) Ligand (BDNF) binds to Trk receptor 2) Trk receptors come together, and phosphorylate each other
  • 37.
  • 38. So many drug targets!!! Examples: 1) Tryptophan 6) Nicotine 10) MAO-I 11) SSRIs
  • 39. Endocrine System Gland Hormone (Function) Pineal Melatonin (light-dark rhythm) Thyroid T3/T4 (energy) Adrenal Cortisol (stress) Pancreas Insulin (glucose) Ovaries Estrogens (2nd sex characteristics) Testes Androgens (2nd sex characteristics)
  • 40. Example • Rats that received ecstasy (MDMA) during adolescence were more sensitive to a 5-HT2 agonist when adults Biezonski et al. (2009). Brain Research, 1252, 87-93.